clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01179503 |
P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
P582 | end time | 2011-05-01 | |
P4135 | maximum age | 89 | |
P2899 | minimum age | 70 | |
P1132 | number of participants | 16 | |
P4844 | research intervention | calcium carbonate | Q23767 |
(5R)-24,25-Dihydroxyvitamin D | Q27161510 | ||
calcium oxalate | Q412399 | ||
P6153 | research site | Wake Forest University | Q392667 |
P580 | start time | 2010-01-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Vitamin D Supplementation, Skeletal Muscle Gene Expression, and Physical Performance in Older Adults |